DW6013
Asset
- Stage
- Phase 1
- Modality
- Small molecule
- Target
- Not known
- 1
- Indication
- 1,357
- Trials
- 1
- Developer
Indications
1Dw6014
Phase 1, Unknown, NCT05823883, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Trials1,357
- Evidence for its targets1
- Competitors12
- Aging relevance1
- Signals15
Every asset’s record: target, stage, trials and the evidence behind it.